These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 6891268

  • 1. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 2. Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.
    Carey RJ, De Veaugh-Geiss J.
    Psychopharmacology (Berl); 1982 Nov; 76(4):341-5. PubMed ID: 6812108
    [Abstract] [Full Text] [Related]

  • 3. The pathophysiology of tardive dyskinesia.
    Klawans HL, Carvey P, Tanner CM, Goetz CG.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [Abstract] [Full Text] [Related]

  • 4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 5. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC, Davis JM.
    Psychopharmacol Commun; 1975 Jul; 1(3):285-93. PubMed ID: 1241453
    [Abstract] [Full Text] [Related]

  • 6. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 7. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH, Diamond BI.
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [Abstract] [Full Text] [Related]

  • 8. Modulation of dopamine receptor sensitivity by estrogen.
    Gordon JH, Borison RL, Diamond BI.
    Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
    [Abstract] [Full Text] [Related]

  • 9. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M, Leonard BE.
    J Neurosci Res; 1980 Jun; 5(4):291-8. PubMed ID: 6107385
    [Abstract] [Full Text] [Related]

  • 10. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC, Vital MA, Frussa-Filho R, Tufik S, Palermo-Neto J.
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [Abstract] [Full Text] [Related]

  • 11. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF, Losey EG, Triezenberg HJ.
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [Abstract] [Full Text] [Related]

  • 12. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 13. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM, Flemenbaum A.
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract] [Full Text] [Related]

  • 14. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG.
    Life Sci; 1986 May 12; 38(19):1707-14. PubMed ID: 3702600
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S, Shimamura H, Hashimoto S, Aihara H.
    Arch Int Pharmacodyn Ther; 1986 Dec 12; 284(2):246-54. PubMed ID: 3827410
    [Abstract] [Full Text] [Related]

  • 16. Animal models for tardive dyskinesia: effects of thioridazine.
    Sayers AC, Bürki HR, Ruch W, Asper H.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep 12; 10(5):291-5. PubMed ID: 616929
    [Abstract] [Full Text] [Related]

  • 17. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Adv Biochem Psychopharmacol; 1980 Sep 12; 24():335-40. PubMed ID: 7190762
    [No Abstract] [Full Text] [Related]

  • 18. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG, Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Balsara JJ.
    Indian J Physiol Pharmacol; 2007 Sep 12; 51(4):375-86. PubMed ID: 18476392
    [Abstract] [Full Text] [Related]

  • 19. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
    Zharkovskiĭ AM, Allikmets LKh, Otter MIa.
    Biull Eksp Biol Med; 1979 Jun 12; 87(6):559-60. PubMed ID: 572714
    [Abstract] [Full Text] [Related]

  • 20. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun 12; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.